Palisade Bio (PALI) EBIT Margin (2011 - 2026)
Palisade Bio's EBIT Margin came in at -2339.60% for Q2 2026.
Analysis
Palisade Bio (PALI) EBIT Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Palisade Bio reported EBIT Margin of -7069.80%; for FY2023, it came in at -5228.00%.
- EBIT Margin carries a five-year change of -2051.29 percentage points (FY2018 to FY2023).
- Going back by year, EBIT Margin was -68764.79% in FY2020 (-12692.99 pp) and -56071.81% in FY2019 (-52895.09 pp).
- The Q2 2026 figure represents the highest quarterly EBIT Margin since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Palisade Bio | 260.39 Mn | -136.05 Mn | - | -2,339.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,339.60% |
| Mar 31, 2023 | -1,011.60% |
| Dec 31, 2020 | -129,800.00% |
| Sep 30, 2020 | -72,640.00% |
| Jun 30, 2020 | -73,640.00% |
| Mar 31, 2020 | -33,064.19% |
| Dec 31, 2019 | -85,302.92% |
| Sep 30, 2019 | -84,967.00% |
| Jun 30, 2019 | -24,301.76% |
| Mar 31, 2019 | -98,262.60% |
| Dec 31, 2018 | -72,192.60% |
| Sep 30, 2018 | -83,306.96% |
| Jun 30, 2018 | -801.18% |
| Mar 31, 2018 | -93,959.80% |
| Dec 31, 2017 | -898.61% |
| Sep 30, 2017 | -103,514.92% |
| Jun 30, 2017 | -168,729.24% |
| Mar 31, 2017 | -169,280.28% |
| Dec 31, 2016 | -64,623.34% |
| Sep 30, 2016 | -196,680.20% |
API Access
Palisade Bio EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PALI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();